tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
PremiumCompany AnnouncementsNurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
2M ago
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
Premium
Company Announcements
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
2M ago
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
Premium
Company Announcements
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
3M ago
NurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026
PremiumCompany AnnouncementsNurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026
5M ago
NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements
Premium
Company Announcements
NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements
5M ago
NurExone Biologic Unveils Promising Preclinical Data on Optic Nerve Regeneration at ARVO 2025
Premium
Company Announcements
NurExone Biologic Unveils Promising Preclinical Data on Optic Nerve Regeneration at ARVO 2025
6M ago
EnerSpar Corp. (NRX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsEnerSpar Corp. (NRX) Q4 Earnings Cheat Sheet
7M ago
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
Premium
Company Announcements
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
8M ago
NurExone Biologic to Showcase Ophthalmology Innovations at MIXiii 2025
Premium
Company Announcements
NurExone Biologic to Showcase Ophthalmology Innovations at MIXiii 2025
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100